Target intelligence / Profile preview

30S ribosomal decoding A-site (30S A-site)

Target
30S A-site
Molecular classification
Ribosomal RNA binding site, Ribosome functional site, Other (structural element of ribonucleoprotein complex)
01

Overview

The **30S ribosomal decoding A-site** is a highly conserved region within the small (30S) subunit of the prokaryotic ribosome, chiefly responsible for monitoring base-pairing between mRNA codons and tRNA anticodons to ensure faithful translation[1][6]. This site, located within the 16S ribosomal RNA component, plays a central role in the decoding process during protein synthesis by selecting correct aminoacyl-tRNAs that match the mRNA codon, with critical involvement of nucleotides A1492 and A1493[1][6]. The A-site is a major target for several classes of antibiotics (including aminoglycosides and spectinomycin) that exert their antibacterial effect by binding to this region, thereby disrupting the accuracy of translation and ultimately inhibiting bacterial growth[1][6]. The structural integrity and conformational dynamics of the A-site are also critical for its function and for mediating interactions with antibiotics. Resistance arises through mutations that alter antibiotic binding without compromising essential decoding functions[1][6]. This target is widely exploited in the development of antibacterial agents due to its key role in the fidelity of protein biosynthesis and its structural and functional divergence from the eukaryotic ribosome[1][6].

Other names
30S ribosomal A site30S A site30S subunit A siteribosomal A site (small subunit)30S ribosomal decoding site
02

Mechanism of action

Inhibition of protein synthesis by binding to the 30S A-site and disrupting decoding fidelity (causing misreading or premature termination) - Stabilization of tRNA–mRNA mismatches leading to bacteriostatic or bactericidal effects

03

Biological functions

Decoding mRNA during translationEnsuring translational fidelitytRNA selectionProtein biosynthesis
04

Disease associations

Infection (site of action for antibiotics targeting pathogenic bacteria)
05

Safety considerations

Off-target effects on mitochondrial ribosomes (for some antibiotics)Ototoxicity and nephrotoxicity (mainly with aminoglycosides in humans)Development of bacterial resistance
06

Interacting drugs

Streptomycin

4 more in the full profile.

07

Biomarkers

Mutations in 16S rRNA (e.g., A1408G, A1492, A1493) conferring resistance to A-site targeting antibiotics

Beyond the preview

Go deeper on 30S ribosomal decoding A-site (30S A-site).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 30S ribosomal decoding A-site (30S A-site).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call